Braun, C. J., Witzel, M., Paruzynski, A., Boztug, K., von Kalle, C., Schmidt, M., & Klein, C. (2014). Gene therapy for Wiskott-Aldrich Syndrome—Long-term reconstitution and clinical benefits, but increased risk for leukemogenesis. Rare Dis.
Dyfyniad Arddull ChicagoBraun, Christian Joerg, Maximilian Witzel, Anna Paruzynski, Kaan Boztug, Christof von Kalle, Manfred Schmidt, and Christoph Klein. "Gene Therapy for Wiskott-Aldrich Syndrome—Long-term Reconstitution and Clinical Benefits, but Increased Risk for Leukemogenesis." Rare Dis 2014.
Dyfyniad MLABraun, Christian Joerg, et al. "Gene Therapy for Wiskott-Aldrich Syndrome—Long-term Reconstitution and Clinical Benefits, but Increased Risk for Leukemogenesis." Rare Dis 2014.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.